Vaccinex, Inc. (VCNX) Operating cash flow 2017–2024
Vaccinex, Inc. (VCNX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.2MFY2024 · since FY2017: -$21.4M → -$16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.2M | +24.3% |
| FY2023 | -$21.4M | -12.1% |
| FY2022 | -$19.1M | +24.6% |
| FY2021 | -$25.3M | +11.7% |
| FY2020 | -$28.6M | +6.7% |
| FY2019 | -$30.7M | -21.5% |
| FY2018 | -$25.3M | -18.2% |
| FY2017 | -$21.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice